The CD4 molecule serves as the principal cell surface receptor common to both the human and simian immunodeficiency viruses (HIV-1, HIV-2 and SIV). Since binding to CD4 is not sufficient to permit virus entry, HIV ‘co-receptors’ have been implicated in mediating the fusion of viral and cellular membranes necessary for completing the entry process. In order to identify candidate co-receptor molecules, a panel of monoclonal antibodies (MAbs) directed against adhesion molecules was tested for the ability of the MAbs to inhibit HIV-1-induced cell fusion (syncytium formation) and HIV-1 entry. Certain antibodies directed against CD18, CD11b and CD11c inhibited HIV-1-induced syncytium formation but not entry, in agreement with previous reports. Interestingly, certain antibodies to ICAM-3 (intercellular adhesion molecule 3) (CD50) significantly inhibited HIV-1-specific entry but not syncytium formation using human SupT1 cells. Only one antibody directed against ICAM-3 significantly inhibited HIV-1-induced syncytium formation, entry and infectivity. Our results suggest that certain epitopes of ICAM-3 may be involved in mediating HIV-1-specific entry into lymphoid and monocytoid cells.
BhatS.,
SpitalnikS. L.,
Gonzalez-ScaranoF.,
SilberbergD. H.1991; Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gpl20. Proceedings of the National Academy of Sciences, USA 88:7131–7134
BraunJ.,
GrasG.,
ChapuisF.,
SommerfeltM. A.,
ClaphamP.,
WeissR. A.,
ÅsjB.,
GluckmanJ. C.,
DormontD.,
Barre-SinoussiF.1994; Analysis of cell surface antigens involved in HIV-1 cell to cell fusion. In Leukocyte Typing V Workshop Session T06. Edited by
SchlossmanS.
Oxford: Oxford University Press; (In press)
BroderC. C.,
DimitrovD. S.,
BlumenthalR.,
BergerE. A.1993; The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 193:483–491
ClaphamP. R.,
BlancD.,
WeissR. A.1991; Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181:703–715
CollmanR.,
HassanN. F.,
WalkerR.,
GodfreyB.,
CutilliJ.,
HastingsJ. C.,
FriedmanH.,
DouglasS. D.,
NathansonN.1989; Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Journal of Experimental Medicine 70:1149–1163
CorbeauP.,
BenkiraneM.,
WeilR.,
DavidC.,
EmilianiS.,
OliveD.,
MawasC.,
SerreA.,
DeveauxC.1993; Ig CD3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. Journal of Immunology 150:290–301
DalgleishA. G.,
BeverleyP. C.,
ClaphamP. R.,
CrawfordD. H.,
GreavesM. F.,
WeissR. A.1984; The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763–766
De FougerollesA. R.,
SpringerT.1992; Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated antigen molecule 1 on resting lymphocytes. Journal of Experimental Medicine 175:185–190
De FougerollesA. R.,
KicksteinL. B.,
SpringerT. B.1993; Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter receptors for lymphocyte function antigen 1. Journal of Experimental Medicine 177:1187–1192
DragicT.,
CharneauP.,
ClavelF.,
AlizonM.1992; Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. Journal of Virology 66:4794–4802
FantiniJ.,
CookD. G.,
NathansonN.,
SpitalnikS. L.,
Gonzalez-ScaranoF.1993; Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gpl20 receptor. Proceedings of the National Academy of Sciences, USA 90:2700–2704
FawcettJ.,
HolnessC. L. L.,
NeedhamL. A.,
TurleyH.,
GatterK. C.,
MasonD. Y.,
SimmonsD. L.1992; Molecular cloning of ICAM-3, a third ligand for LFA-1 constitutively expressed on resting leukocytes. Nature 360:481–484
GoldingH.,
DimitrovD. S.,
BlumenthalR.1992; LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion. AIDS Research and Human Retroviruses 8:1593–1598
HarouseJ. M.,
BhatS.,
SpitalnikS. L.,
LaughlinM.,
StefanoK.,
SilberbergD. H.,
Gonzalez-ScaranoF.1991; Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320–323
HarringtonR. D.,
GeballeA. P.1993; Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. Journal of Virology 67:5939–5947
HealeyD.,
DiandaL.,
MooreJ. P.,
McDougalJ. S.,
MooreM. J.,
EstessP.,
BuckD.,
KwongP. D.,
BeverleyP. C. L.,
SattentauQ. J.1990; Novel anti-CD4 monoclonal antibodies separate HIV infection and fusion of CD4+ cells from virus binding. Journal of Experimental Medicine 172:1233–1242
HendersonI. C.,
LieberM. M.,
TodaroG.1974; Mink cell line Mv1Lu (CCL64) focus formation and generation of non-producer transformed cell lines with murine and feline sarcoma viruses. Virology 60:282–287
Hernandez-CasellesT.,
RubioG.,
CampaneroM. R.,
Del PozoM. A.,
MuroM.,
Sanchez-MadridF.,
AparicioP.1993; ICAM-3, the third LFA-1 counter receptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. European Journal of Immunology 23:2799–2806
JuanM.,
VilellaR.,
MilaJ.,
YagueJ.,
MirallesA.,
CampbellK. S.,
FriedrichR. J.,
CambierJ.,
VivesJ.,
De FougerollesA. R.,
SpringerT.1993; CDw50 and ICAM-3: Two names for the same molecule. European Journal of Immunology 23:1508–1512
KlicksteinL. B.,
De FougerollesA. R.,
YorkM. R.,
SpringerT. A.1993; Localisation of the LFA-1 binding site on ICAM-3 (CD50) by epitope mapping and deletion mutagenesis. Vth International Conference and Workshop on Human Leukocyte Differentiation Antigens Abstract no. AS050. Workshop session AS02. Tissue Antigens 42270
MaddonP. J.,
DalgleishA. G.,
McDougalJ. S.,
ClaphamP. R.,
WeissR. A.,
AxelR.1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and in the brain. Cell 47:333–348
PanteleoB. G.,
ButiniL.,
GraziosiC.,
PoliG.,
SchnittmanS. M.,
GreenhouseJ. J.,
GallinJ. I.,
FauciA.1991; Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission. Journal of Experimental Medicine 173:511–514
SattentauQ. J.,
ClaphamP. R.,
WeissR. A.,
BeverleyP. C. L.,
MontagnierL.,
AlhabiM. F.,
GluckmanJ-C.,
KlatzmannD.1988; The human and simian immunodeficiency viruses, HIV-1, HIV-2 and SIV interact with similar epitopes on their cell surface receptor, the CD4 molecule. AIDS 2:101–105
SteinB. S.,
GowdaS. D.,
LifsonJ. D.,
PenhallowR. C.,
BenschK. G.,
EngelmanE. G.1987; pH-independent HIV entry into CD4-positive T cells via envelope fusion to the plasma membrane. Cell 49:659–668
SundqvistV-A.,
AlbertJ.,
OhlssonE.,
HinkulaJ.,
FenyoE. M.,
WahrenB.1989; HIV-1 p24 antigenic variation in tissue culture of isolates with defined growth characteristics. Journal of Medical Virology 29:170–175
TersmetteM.,
Van DongenJ. J. M.,
ClaphamP. R.,
GoedeR. E. Y.,
Wolvers-TetteroI. L. M.,
Guerts Van KesselA.,
HuismanJ. G.,
WeissR. A.,
MiedemaF.1989; Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. Virology 168:267–273
ValentinA.,
LundinK.,
PattarroyoM.,
ÅsjöB.1990; The leukocyte adhesion glycoprotein CD18 participates in HIV-induced syncytia formation in monocytoid and T cells. Journal of Immunology 144:934–937
ValentinA.,
NilssonK.,
ÅsjöB.1994; Tropisms for primary monocytes and monocytoid cell lines are separate features of HIV-1 variants. Journal of Leukocyte Biology 56:225–229
VazeuxR.,
HoffmanP. A.,
TomitaJ. K.,
DickinsonE. S.,
JasmanR. L.,
St.JohnT.,
GallatinM.1992; Cloning and characterisation of a new intercellular adhesion molecule ICAM-R. Nature 360:485–488